Involvement of the tumor necrosis factor
β
Krittaya Sutheesophon; Noriko Nishimura; Yukiko Kobayashi; Yutaka Furukawa; Miki
π
Article
π
2005
π
John Wiley and Sons
π
English
β 416 KB
## Abstract Inhibition of histone deacetylase (HDAC) is a novel strategy for the treatment of leukemias via restoration of aberrantly silenced genes. In this study, we conducted a detailed analysis of antiβleukemic effects of an HDAC inhibitor (HDI), depsipeptide (FK228), using myeloid leukemia cel